| Dissecting the CD93-Multimerin 2 interaction involved in cell adhesion and migration of the activated endothelium F Galvagni, F Nardi, O Spiga, A Trezza, G Tarticchio, R Pellicani, ... Matrix Biology 64, 112-127, 2017 | 66 | 2017 |
| HTRA1 and TGF-β1 concentrations in the aqueous humor of patients with neovascular age-related macular degeneration GM Tosi, E Caldi, G Neri, E Nuti, D Marigliani, S Baiocchi, C Traversi, ... Investigative ophthalmology & visual science 58 (1), 162-167, 2017 | 56 | 2017 |
| CD93 and dystroglycan cooperation in human endothelial cell adhesion and migration F Galvagni, F Nardi, M Maida, G Bernardini, S Vannuccini, F Petraglia, ... Oncotarget 7 (9), 10090-10103, 2016 | 52 | 2016 |
| The small GTPase Rab5c is a key regulator of trafficking of the CD93/Multimerin-2/β1 integrin complex in endothelial cell adhesion and migration S Barbera, F Nardi, I Elia, G Realini, R Lugano, A Santucci, GM Tosi, ... Cell Communication and Signaling 17 (1), 1-15, 2019 | 33 | 2019 |
| CD93 as a potential target in neovascular age‐related macular degeneration GM Tosi, E Caldi, B Parolini, P Toti, G Neri, F Nardi, C Traversi, ... Journal of Cellular Physiology 232 (7), 1767-1773, 2017 | 26 | 2017 |
| Tumor genotype, location, and malignant potential shape the immunogenicity of primary untreated gastrointestinal stromal tumors D Gasparotto, M Sbaraglia, S Rossi, D Baldazzi, M Brenca, A Mondello, ... JCI insight 5 (22), 2020 | 14 | 2020 |
| Assessing gene function in human B cells: CRISPR/Cas9-based gene editing and mRNA-based gene expression in healthy and tumour cells F Nardi, L Pezzella, R Drago, A Di Rita, M Simoncelli, G Marotta, ... European journal of immunology, 2022 | 2 | 2022 |
| Bioinformatic approaches to predict mutation effects in the binding site of the proangiogenic molecule CD93 V Cicaloni, M Karmakar, L Frusciante, F Pettini, A Visibelli, M Orlandini, ... Frontiers in Bioinformatics, 54, 0 | 1 | |
| Cross-talk between lipid and metal homeostasis regulates fitness of tumour cells in leukemia F Nardi, A Di Rita, L Pezzella, R Drago, R Del Prete, S Ciofini, D Licastro, ... FEBS OPEN BIO 12, 108-108, 2022 | | 2022 |
| Gene editing and expression in hard-to-manipulate primary tumour cells by CRISPR/Cas9 and mRNA technology F Nardi, A Di Rita, L Pezzella, S Ciofini, A Gozzetti, M Bocchia, ... FEBS OPEN BIO 11, 411-411, 2021 | | 2021 |
